Literature DB >> 22588991

Magnetic resonance imaging in valvular heart disease: clinical application and current role for patient management.

Gregor Sommer1, Jens Bremerich, Gunnar Lund.   

Abstract

Noninvasive imaging provides important information on cardiac anatomy and function and is a key element in clinical management of valvular heart disease (VHD). Beside echocardiography, which is still considered the first-line modality for assessment of valvular anatomy and longitudinal evaluation of VHD, cardiovascular magnetic resonance (CMR) has evolved during the last two decades as an essential tool for evaluation of cardiac diseases. Today, CMR not only represents the reference standard for measuring cardiac volumes, function, and mass, but also enables accurate assessment of morphology and function of cardiac valves. It can play an important role in clinical decision-making for patients with VHD. This review addresses current applications and limitations of CMR imaging techniques that are used in VHD including cine-balanced steady-state free precession (b-SSFP), phase contrast MR (pcMR), gradient-recalled echo (GRE), and turbo-spin echo (TSE) sequences. Moreover, it describes their application for evaluation of valvular pathologies and gives an overview on the current role of valvular CMR in patient management.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22588991     DOI: 10.1002/jmri.23544

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  8 in total

1.  Multicenter review: role of cardiovascular magnetic resonance in diagnostic evaluation, pre-procedural planning and follow-up for patients with congenital heart disease.

Authors:  Nicolò Schicchi; Aurelio Secinaro; Giuseppe Muscogiuri; Paolo Ciliberti; Benedetta Leonardi; Teresa Santangelo; Carmela Napolitano; Giacomo Agliata; Maria Chiara Basile; Francesca Guidi; Paolo Tomà; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2015-12-11       Impact factor: 3.469

2.  Gradient- and spin-echo (GRASE) MR imaging: a long-existing technology that may find wide applications in modern era.

Authors:  Mei-Lan Chu; Cheng-Ping Chien; Wen-Chau Wu; Hsiao-Wen Chung
Journal:  Quant Imaging Med Surg       Date:  2019-09

Review 3.  Magnetic resonance and computed tomography imaging of the structural and functional changes of pulmonary arterial hypertension.

Authors:  Mark L Schiebler; Sanjeev Bhalla; James Runo; Nizar Jarjour; Alejandro Roldan; Naomi Chesler; Christopher J François
Journal:  J Thorac Imaging       Date:  2013-05       Impact factor: 3.000

Review 4.  Role of Cardiac Magnetic Resonance Imaging in Valvular Heart Disease: Diagnosis, Assessment, and Management.

Authors:  Roshin C Mathew; Adrián I Löffler; Michael Salerno
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

5.  Saturation recovery-prepared magnetic resonance angiography for assessment of left atrial and esophageal anatomy.

Authors:  Johannes Siebermair; Eugene G Kholmovski; Douglas Sheffer; Joyce Schroeder; Leif Jensen; Mobin Kheirkhahan; Alex A Baher; Majd M Ibrahim; Theresa Reiter; Tienush Rassaf; Reza Wakili; Nassir F Marrouche; Christopher J McGann; Brent D Wilson
Journal:  Br J Radiol       Date:  2021-06-11       Impact factor: 3.629

6.  A case report and analysis of hypertrophic obstructive cardiomyopathy causing an illusion of aortic stenosis.

Authors:  Ying Wang; Yue Ming Zhang; Jing Guang Dong; Li Jie Cheng; Guan Hua Jiang; Jian Wei Zheng; Wen Zhou Yu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

Review 7.  The Role of Cardiac Magnetic Resonance in Aortic Stenosis and Regurgitation.

Authors:  Marco Guglielmo; Chiara Rovera; Mark G Rabbat; Gianluca Pontone
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-04

8.  Evaluation of aortic stenosis using cardiovascular magnetic resonance: a systematic review & meta-analysis.

Authors:  Kei Woldendorp; Paul G Bannon; Stuart M Grieve
Journal:  J Cardiovasc Magn Reson       Date:  2020-06-15       Impact factor: 5.364

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.